✦ LIBER ✦

Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study

✍ Scribed by Sawaki, Akira; Ohashi, Yasuo; Omuro, Yasushi; Satoh, Taroh; Hamamoto, Yasuo; Boku, Narikazu; Miyata, Yoshinori; Takiuchi, Hiroya; Yamaguchi, Kensei; Sasaki, Yasutsuna; Nishina, Tomohiro; Satoh, Atsushi; Baba, Eishi; Tamura, Takao; Abe, Takashi; Hatake, Kiyohiko; Ohtsu, Atsushi

Book ID: 113057356
Publisher: Springer
Year: 2011
Tongue: English
Weight: 268 KB
Volume: 15
Category: Article
ISSN: 1436-3291
DOI: 10.1007/s10120-011-0118-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN116 ANALYSIS OF THE EQ-5D QUESTIONNAI

PCN116 ANALYSIS OF THE EQ-5D QUESTIONNAIRE FOR PATIENTS WITH ADVANCED HER2-POSITIVE GASTRIC CANCER (HER2+ AGC) BASED ON THE TRASTUZUMAB FOR GASTRIC CANCER (TOGA) STUDY

✍ R Aultman; A Urspruch 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Phase II study of trastuzumab and cispla

Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer

✍ Cristina Grávalos; Carlos Gómez-Martín; Fernando Rivera; Inmaculada Alés; Bernar 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 424 KB

PCN20 Analysis of Using Trastuzumab for

PCN20 Analysis of Using Trastuzumab for the Treatment of Advanced Gastric Cancer With HER2 Positive

✍ Lechuga, D.; Gay, J.G.; Alva, M.; Sanchez-kobayashi, R. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Pharmacokinetic analysis of capecitabine

Pharmacokinetic analysis of capecitabine and cisplatin in combination with trastuzumab in Japanese patients with advanced HER2-positive gastric cancer

✍ Taroh Satoh; Yasushi Omuro; Yasutsuna Sasaki; Yasuo Hamamoto; Narikazu Boku; Tak 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 227 KB

3032 POSTER Health-related Quality of Li

3032 POSTER Health-related Quality of Life in Patients With HER2-positive Advanced Gastric or Gastroesophageal Junction Cancer With High HER2 Expression Levels – Exploratory Analysis of the Phase III ToGA Study

✍ L. Shen; Y.K. Kang; M. Lichinitser; H.C. Chung; A. Ohtsu; Y.J. Bang; E. Van Cuts 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Trastuzumab in combination with chemothe

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

✍ Yung-Jue Bang; Eric Van Cutsem; Andrea Feyereislova; Hyun C Chung; Lin Shen; Aki 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 332 KB